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ABSTRACT
Objective: The objective of this study is to assess the utilization of drug information services and create awareness for enhanced utilization of drug 
information center in the hospital.
Methods: A retro-prospective observational study conducted from September 2015 to February 2016. The data obtained from drug information 
(DI) request, documentation, and feedback forms are analyzed for the parameters such as professional status of enquirer, mode of receipt of query, 
purpose of enquiry, time frame to reply, and references used. Awareness about drug information services was created in the hospital by circulating 
brochures and interacting with health-care professionals.
Results: A total of 943 queries were retrospectively analyzed. Most of the queries obtained from a post-graduate/intern (50.27%), during ward 
rounds (57.48%), and asked for updating knowledge (76.35%). Frequently asked questions were about indications of drugs (18.60%). Mostly 
answers given as printed (66.70%), replied within a day (46.45%) by using Micromedex (54.72%). The majority of the enquirers rated the DI services 
as good (54.93%). A total of 394 queries were prospectively analyzed. Most of the queries obtained from physicians (42.23%), during ward rounds 
(59.89%), and asked for updating knowledge (49.49%). Frequently asked questions were about adverse drug reaction (21.28%). The mode of reply to 
the queries given mostly in printed format (41.14%), replied within 2-4 hrs (33.75%) by using Micromedex (40.56%). The majority of the enquirers 
rated the DI services as good (46.98%).
Conclusion: The drug information services provided were useful for various health-care professionals to maintain rational drug therapy by giving 
unbiased and well-reviewed information.
Keywords: Drug information center, Drug information service, Drug information query, Micromedex drug database.
INTRODUCTION
Drug information service is the service that encompasses the activities 
of specially trained individuals to provide accurate, unbiased, factual 
information, primarily in response to patient-oriented drug problems 
received from various members of the health-care team [1]. These 
activities are undertaken by the especially well-trained individuals, 
i.e., clinical pharmacist and doctor of pharmacy professionals who are 
qualified and registered under the Board of State Pharmacy Council in 
providing information to optimizing the drug therapy [2]. Providing 
drug information is a fundamental responsibility of all pharmacists 
irrespective of the practice setting [3]. The World Health Organization 
(WHO) stated that drug information center (DIC) is a core component 
of national programs to promote the rational use of drugs [4]. Drug 
information is key to preventing medication errors. Such information 
leads to enhanced quality of patient care and thus improved patient 
outcome [5].
Drug use is a complex practice even a small mistake, and incomplete 
information has catastrophic implication in patients and results into 
noncompliance, therapeutic failure, overdosage, medication errors, drug 
interactions and adverse drug reactions (ADRs), which concurrently 
lead to ineffective and irrational use of drugs. According to the WHO, 
60% of drug related problems can be prevented with appropriate 
information of drugs [6]. Lack of time is some of the factors that make 
the physicians unable to update their knowledge about drugs which 
have resulted in an increasing demand for independent and unbiased 
information about drugs for better patient care [7]. Information must 
be available in a format suitable for health practitioners and relevant to 
current clinical practice [8]. In India, irrational use of drugs is common, 
and this has led to antibiotic resistance, ADRs, drug interactions, and 
other drug-related problems [9].
The primary function of the center is in accessing to the drug information 
source and dissemination of the same to the requestor [10]. Possible 
sites for the location of a drug information center include the ministry 
of health, hospital, university, non-government organization, and the 
private sector [11]. According to available data, these services can help 
to detect and prevent ADRs, medication errors and promote rational use 
of drugs [12]. The center was intended to be utilized as a source center 
where people could call or contact health-care professionals and ask 
medicine-related questions [13]. DICs aims to achieve the quality use of 
medicines by providing and communicating timely, accurate, balanced 
and comprehensive information on drugs and their usage [14].
In 1962, the first drug information center was initialized at the University 
of Kentucky Medical Center [15]. In India, Rosemary sharp, a missionary 
from UK, started the first drug information center at Christian Medical 
College, Vellore in the early 1970s [16]. Later the Karnataka State 
Pharmacy Council (KSPC) established its Drug Information Centre in 
August 1997 to disseminate unbiased drug information to health-
care professionals. The center has been registered with International 
Register of Drug Information Services [17].
Recognizing the need to provide organized drug information to 
health-care professionals as well as consumers, the WHO India 
Country Office in collaboration with the KSPC has supporting the 
establishment of 5 drug information centers. These centers have 
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been established in Haryana (Sirsa), Chattisgarh (Raipur), Rajasthan 
(Jaipur), Assam (Dibrugarh), and Goa (Panaji). They started 
functioning in 2007 [18].
Quality assurance in DIS can be deciding what services are to be 
provided, providing them, measuring how well the services were 
provided, and if the services were not found to be acceptable or 
optimal, undertaking some correctional activity to ensure that future 
services will be acceptable [19]. In developing countries like India, 
there are only a few DICs and are limited by lack trained staff, funds 
and by limited access to current literature. This clearly signifies 
that there is a need for periodic evaluation of mode of functioning 
and quality of services provided by the DIC [20]. Pharmacists are 
challenged with keeping up to date with an increasing number of new 
drugs and literature [21].
WHO recognizes independent drug information centers as a core 
component of national programs to promote the rational use of 
drugs [22].
In 2013, the drug information center was established by Bapuji 
Pharmacy College in S.S Institute of Medical Sciences and Research 
Centre (SSIMS and RC), Karnataka. The center focuses on providing 
unbiased drug information, well referenced, critically evaluated 
and up to date information which promotes the safe and effective 
use of medication. Clinical pharmacists and the staff working in our 
department were specially trained under drug information center with 
adequate knowledge on clinical research, pharmacology, pharmaceutics, 
pharmacotherapeutics, and statistics.
Objectives
The objective of the study was to assess the utilization of drug 
information services and creating awareness for enhanced utilization 
of DIC in a tertiary care teaching hospital.
METHODS
A retro-prospective observational analysis of DIC was conducted in a 
tertiary care teaching hospital in Davanagere for 6-months.
Inclusion criteria
•	 Drug	 information	provided	 to	various	health-care	professionals	
(doctors, nurses, paramedical).
•	 Drug	queries	generated	or	requisitioned	from	various	departments	
in the entire hospital.
Exclusion criteria





The ethical clearance for the study was obtained from the Institutional 
Ethical Committee of Bapuji Pharmacy College, Davangere.
Study procedure
The drug information request and documentation forms from the DIC 
were retro-prospectively analyzed for 6-months, for collecting the 
following parameters such as professional status of enquirer, speciality 
of practice, mode of receipt of query, purpose of enquiry, time frame to 
reply, and references used. The quality of services provided by the DIC 
was assessed on feedback questionnaire given by the enquirer, which 
comprised questions pertaining to awareness, utilization, opinion, 
etc. Education program was conducted in the hospital for the students 
of Pharm. D. regarding their role in patient care and the systematic 
approach to answering drug information enquiries. Awareness about 
DIC and its services was created in the hospital by circulating brochures 
and interacting with health-care professionals.
RESULTS
Retrospective analysis
A total number of 943 queries were received to drug information center 
of SSIMS and RC from January 2013 to August 2015 (Table 1).
Among these, most of the queries were given by post-graduate (PG)/
interns 474 (50.27%) followed by physician 282 (29.90%) and 
pharmacist 68 (7.21%) (Table 2).
Out of 943 queries, 542 (57.48%) were obtained during ward rounds, 
393 (41.67%) via direct access and 8 (0.85%) by others (Table 3).
Among these, 719 (76.25%) were enquired to update knowledge, 
221 (23.43%) for better patient care and 3 (0.32%) for other purposes 
(Table 4).
Our retrospective analysis illustrates that most of the queries were 
asked regarding indication 358 (18.60%) and least regarding poisoning 
22 (1.14%) (Table 5).
Around 629 (66.70%) queries were given as printed material, 
197 (20.89%) as written, 62 (6.58%) as verbal and 55 (5.83%) in both 
written and verbal form (Table 6).
Time frame for reply for the majority of queries was within a day 
(46.45%) followed by within 2-4 hrs (27.78%) (Table 7).
Table 1: Year‑wise distribution of queries







1 2013 (January-December) 237 20
2 2014 (January-December) 401 33
3 2015 (January-August) 305 38
Table 2: Professional status of enquirer
S. No. Professional status of 
enquirer
Number of queries (%)
1 PG/Intern 474 (50.27)
2 Physician 282 (29.90)
3 Pharmacist 68 (7.21)
4 Nurse 64 (6.79)
5 Surgeon 37 (3.92)
6 Others 8 (0.85)
7 Resident 6 (0.64)
8 Dermatologist 4 (0.42)
PG: Post-graduate
Table 3: Mode of receipt of the queries
S. No. Mode of receipt of the query Number of queries (%)
1 During ward rounds 542 (57.48)
2 Direct access 393 (41.67)
3 Others 8 (0.85)
4 Telephone 0 (0)
Table 4: Reason of requisition
S. No. Reason of requisition Number of queries (%)
1 Update knowledge 719 (76.25)
2 Better patient care 221 (23.43)
3 Others 3 (0.32)
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About 516 (54.72%) queries were answered by using Micromedex 
followed by textbooks 243 (25.77%), websites 107 (11.35%), and 
journals 77 (8.16%) (Table 8).
Nearly 77 (8.16%) queries were answered by using primary resources, 
623 (66.07%) by secondary resources and 243 (25.77%) by using 
tertiary resources (Table 9).
The majority of the requesters rated the provided drug information as 
good 518 (54.93%) and satisfactory 142 (15.06%) (Table 10).
Prospective analysis
A total of 394 queries were received from September 2015 to February 
2016. The average number of queries received per month was 67. 
Most of the queries were obtained in the month of February (20.81%) 
(Table 11).
Out of 394 queries, most of the queries were given by physicians 
166 (42.13%) followed by PG/interns 87 (22.08%) and surgeon 
50 (12.69%) (Table 12).
Out of 394 queries, 236 (59.89%) were obtained during ward rounds, 
140 (35.53%) via direct access, 10 (2.55%) by others and 8 (2.03%) 
through telephone (Table 13).
Among the queries, 195 (49.49%) were enquired to update knowledge, 
194 (49.23%) for better patient care and 5 (1.28%) for other purposes 
(Table 14).
Our prospective analysis illustrates that most of the queries were asked 
regarding ADR of the drug 202 (21.28%) and least regarding poisoning 
9 (1.09%) (Table 15).
Table 5: Types of drug query
S. No. Types of drug query Number of queries (%)
1 Indication 358 (18.60)
2 ADR 289 (15.02)
3 Dosage/administration 271 (14.08)
4 Drug therapy 228 (11.84)
5 Others 192 (9.97)
6 Pharmacokinetics 178 (9.25)
7 Interactions 118 (6.13)
8 Availability/cost 108 (5.61)
9 Efficacy 100 (5.19)
10 Pregnancy/lactation 61 (3.17)
11 Poisoning 22 (1.14)
ADR: Adverse drug reaction
Table 6: Mode of reply
S. No. Mode of reply Number of queries (%)
1 Printed material 629 (66.70)
2 Written 197 (20.89)
3 Verbal 62 (6.58)
4 Both (written and verbal) 55 (5.83)
Table 7: Time frame for reply
S. No. Time frame to reply Number of queries (%)
1 Within a day 438 (46.45)
2 Within 2-4 hrs 262 (27.78)
3 Within 1-2 days 145 (15.38)
4 Immediately 98 (10.39)
Table 8: Data sources used for information
S. No. Sources used for information Number of queries (%)
1 Micromedex 516 (54.72)
2 Textbooks 243 (25.77)
3 Website 107 (11.35)
4 Journals 77 (8.16)
5 Others 0 (0)
Table 9: Categorization of data sources used
S. No. Data sources used Number of queries (%)
1 Primary resources 77 (8.16)
2 Secondary resources 623 (66.07)
3 Tertiary resources 243 (25.77)
Table 10: Quality of DI provided
S. No. Quality of DI provided Number of queries (%)
1 Good 518 (54.93)
2 Satisfactory 142 (15.06)
3 Excellent 122 (12.94)
4 Can improve 98 (10.39)
5 Fair 60 (6.36)
6 Poor 3 (0.32)
DI: Drug information
Table 11: Month‑wise distribution of received queries
S. No. Months Number of queries (%)
1 September 2015 52 (13.20)
2 October 2015 68 (17.26)
3 November 2015 45 (11.42)
4 December 2015 70 (17.77)
5 January 2016 77 (19.54)
6 February 2016 82 (20.81)
Table 12: Professional status of enquirer
S. No. Professional status of 
enquirer
Number of queries (%)
1 Physician 166 (42.13)
2 PG/interns 87 (22.08)
3 Surgeon 50 (12.69)
4 Nurse 47 (11.93)
5 Dermatologist 17 (4.32)
6 Pharmacist 17 (4.32)
7 Resident 9 (2.28)
8 Others 1 (0.25)
Table 13: Mode of receipt of queries
S. No. Mode of receipt of queries Number of queries (%)
1 During ward rounds 236 (59.89)
2 Direct access 140 (35.53)
3 Other 10 (2.55)
4 Telephone 8 (2.03)
Table 14: Reason of requisition
S. No. Reason of requisition Number of queries (%)
1 Update knowledge 195 (49.49)
2 Better patient care 194 (49.23)
3 Others 5 (1.28)
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Our prospective study has shown that 162 (41.14%) queries were given 
as printed material, 129 (32.74%) as written, 58 (14.70%) as both 
written and verbal and 45 (11.42%) in verbal form (Table 16).
Time frame for reply for 133 (33.75%) queries were within 2-4 hrs, 
117 (29.69%) were within a day, 93 (23.66%) were within 1-2 days and 
for 51 (12.90%) were immediately (Table 17).
About 203 (41.17%) queries were answered by using Micromedex 
followed by textbooks 135 (27.38%), journals 100 (20.28%) and 
websites 55 (11.17%) (Table 18).
Nearly 100 (20.28%) queries were answered by using primary 
resources, 258 (52.34%) by secondary resources and 135 (27.38%) by 
using tertiary resources (Table 19).
Majority of the requesters rated the provided drug information as good 
185 (46.95%) and excellent 74 (18.77%) (Table 20).
By comparing the results of both retrospective and prospective studies 
indicates an average of 29 queries/month was received in retrospective 
analysis and 67 queries/month in prospective analysis period.
DISCUSSION
Drug information service can help to detect and prevent ADRs, 
medication errors and promote rational use of drugs. Therefore, these 
centers can positively improve the outcome of therapy.
There was a gradual increase in the number of utilization of drug 
information service during the prospective analysis period. It was 
due to the impact of awareness created in the hospital regarding drug 
information center.
After analyzing the queries, the physicians maximally utilized the drug 
information services which comprise more than 40% of consult volume 
compared to PG/interns, surgeons and other health-care professionals. 
Most of the queries were received during ward rounds (59.89%), which 
could be attributed to the easy accessibility of clinical pharmacist that 
prompts other health-care professionals to utilize the services. This was 
similar to the results of the studies conducted by Subash et al. (2009) 
and Venkatraghavan et al. In the study conducted by Subash et al., 44% 
of queries received during ward round, whereas it was estimated as 
61.5% in the study of Venkatraghavan et al.
The reason of requisition of most of the queries was to update 
knowledge (49.49%) and for better patient care (49.23%). This is 
comparable with the study conducted by Jeevangi et al., which shown 
56.56% and 31.15%, respectively.
In this study, queries on ADR (21.28%) were predominant. This result 
closely matches with the findings in a study done by Rajanandh et al. 
which showed that maximum queries were on ADR (35.90%). While 
in the study conducted by Subash et al., in 2013, most commonly asked 
questions were on drug therapy (34%). Our findings indicate that 
physicians give more importance to ADRs of various drugs.
In this study, 33.75% of the queries were answered within 2-4 hrs, 
which is in contrast to the study findings done by Jayasutha et al. where 
majority of the queries were replied within a day (86%). This is because 
of the ready availability of authenticated drug information software and 
ease of getting information from these sources.
In our study, most of the queries were answered in printed material 
(41.14%). This result was similar to the result (52.46%) of the study 
done by Mudigubba et al.
To answer the queries, primary, secondary and tertiary sources 
were used. Among them, most of the queries were answered by 
using Micromedex (41.17%). These findings are similar to the 
studies conducted by Aida et al. and Jeevangi et al. where it was 
37.3% and 52.45%, respectively. The availability of recent and relevant 
information in Micromedex makes clinical pharmacists to use it as a 
major source of providing DI.
Feedback responses clearly demonstrated that majority of enquirers 
were very much satisfied with the performance of the service and 
Table 15: Types of drug query
S. No. Types of drug query Number of queries (%)
1 ADR 202 (21.28)
2 Indications 152 (16.32)
3 Dosage/administration 138 (14.52)
4 Efficacy 72 (8.72)
5 Drug therapy 71 (8.07)
6 Interactions 64 (7.27)
7 Others 48 (5.45)
8 Pregnancy/lactation 47 (5.34)
9 Availability/cost 46 (5.23)
10 Pharmacokinetics 40 (4.55)
11 Poisoning 9 (1.09)
ADR: Adverse drug reactions
Table 16: Mode of reply
S. No. Mode of reply Number of queries (%)
1 Printed material 162 (41.14)
2 Written 129 (32.74)
3 Both (written and verbal) 58 (14.70)
4 Verbal 45 (11.42)
Table 17: Time frame for reply
S. No. Time frame to reply Number of queries (%)
1 Within 2-4 hrs 133 (33.75)
2 Within a day 117 (29.69)
3 Within 1-2 days 93 (23.66)
4 Immediately 51 (12.90)
Table 18: Data sources used for information
S. No. Data sources used for 
information
Number of queries (%)
1 Micromedex 203 (41.17)
2 Textbooks 135 (27.38)
3 Journals 100 (20.28)
4 Websites 55 (11.17)
5 Others 0 (0)
Table 19: Categorization of data sources used
S. No. Data sources used Number of queries (%)
1 Primary resources 100 (20.28)
2 Secondary resources 258 (52.34)
3 Tertiary resources 135 (27.38)
Table 20: Quality of the DI provided
S. No. Quality of the DI provided Number of queries (%)
1 Good 185 (46.95)
2 Excellent 74 (18.77)
3 Satisfactory 56 (14.21)
4 Fair 46 (11.68)
5 Can improve 33 (8.38)
6 Poor 0 (0)
DI: Drug information
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rated as good (46.95%) and excellent (18.77%). Similar to the 
study conducted by Walli et al. where it showed that majority of 
the enquirers rated the provided drug information services as good 
(48.90%).
CONCLUSION
Awareness for enhanced utilization of drug information services is 
an effective tool for better patient care. Therefore, it is necessary 
to perform such studies frequently for accessing and analyzing the 
utilization of drug information services in the hospital.
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